IQ EQ Fund Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,764
Closed -$373K 249
2021
Q1
$373K Buy
5,764
+976
+20% +$62.9K 0.07% 198
2020
Q4
$279K Hold
4,788
0.06% 199
2020
Q3
$303K Hold
4,788
0.09% 165
2020
Q2
$368K Hold
4,788
0.12% 118
2020
Q1
$358K Sell
4,788
-1,286
-21% -$88.9K 0.15% 105
2019
Q4
$395K Hold
6,074
0.13% 113
2019
Q3
$385K Hold
6,074
0.12% 120
2019
Q2
$410K Buy
+6,074
New +$400K 0.13% 118
2018
Q4
$380K Hold
6,074
0.14% 101
2018
Q3
$489K Sell
6,074
-347
-5% -$26.2K 0.13% 106
2018
Q2
$455K Buy
+6,421
New +$453K 0.12% 99
2017
Q1
$1.98M Sell
25,770
-4,179
-14% -$294K 0.37% 53
2016
Q4
$2.46M Sell
29,949
-12,747
-30% -$947K 0.45% 47
2016
Q3
$3.64M Sell
42,696
-3,481
-8% -$283K 0.67% 41
2016
Q2
$4.2M Sell
46,177
-9,733
-17% -$864K 0.79% 40
2016
Q1
$5.45M Sell
55,910
-20,989
-27% -$1.89M 1% 34
2015
Q4
$8.67M Buy
76,899
+4,268
+6% +$444K 1.49% 23
2015
Q3
$7.73M Sell
72,631
-7,716
-10% -$857K 1.25% 27
2015
Q2
$10.2M Buy
80,347
+9,089
+13% +$993K 1.47% 29
2015
Q1
$7.88M Sell
71,258
-9,828
-12% -$998K 1.06% 32
2014
Q4
$7.64M Buy
+81,086
New +$8.39M 1.11% 30

Other funds holding GILD

IQ EQ Fund Management's GILD Position: Q2 2021 in Review

IQ EQ Fund Management sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 5,764 shares — an estimated $373K sold.

IQ EQ Fund Management first reported a position in GILD in Q4 2014 and held it in 21 quarters. The position peaked at $10.2M in Q2 2015. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • IQ EQ Fund Management reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • IQ EQ Fund Management sold 5,764 Gilead Sciences shares in Q2 2021, an estimated $373K.
  • IQ EQ Fund Management first reported a position in Gilead Sciences in Q4 2014 and held it in 21 quarters.
  • IQ EQ Fund Management's Gilead Sciences position peaked at $10.2M in Q2 2015.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on IQ EQ Fund Management's 13F filing for Q2 2021, filed 19 Jul 2021.